Cargando…
Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
BACKGROUND: Enthesitis is a hallmark of spondyloarthritis (SpA) with a substantial impact on quality of life. Reports of treatment effectiveness across individual enthesitis sites in real-world patients with axial SpA (axSpA) are limited. We investigated the evolution of enthesitis following tumor n...
Autores principales: | Nissen, Michael J., Möller, Burkhard, Ciurea, Adrian, Mueller, Ruediger B., Zueger, Patrick, Schulz, Martin, Ganz, Fabiana, Scherer, Almut, Papagiannoulis, Eleftherios, Hügle, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188725/ https://www.ncbi.nlm.nih.gov/pubmed/34107999 http://dx.doi.org/10.1186/s13075-021-02534-7 |
Ejemplares similares
-
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
por: Micheroli, Raphael, et al.
Publicado: (2017) -
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
por: Ciurea, Adrian, et al.
Publicado: (2023) -
Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
por: Hebeisen, Monika, et al.
Publicado: (2019) -
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
por: Ciurea, Adrian, et al.
Publicado: (2022) -
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry
por: Ciurea, Adrian, et al.
Publicado: (2023)